ライフサイエンスコーパス: bacterial RNA

1 ated by cytosolic poly I:C, reoviral RNA, or bacterial RNA.

2 -1beta induction and caspase-1 activation by bacterial RNA.

3 able on mechanisms underlying recognition of bacterial RNA.

4 ey has adapted to a role in the digestion of bacterial RNA.

5 creased demands for the enzyme for digesting bacterial RNA.

6 ll RNAs in the cell and is relatively stable bacterial RNA.

7 RNAs are homologous (of common ancestry) to bacterial RNA.

8 e profiled, including mRNA, miRNA, piRNA and bacterial RNA.

9 hagocytosis, impairing endosomal delivery of bacterial RNA.

10 ently, PKR has been found to be activated by bacterial RNA.

11 (FnCas9) is capable of targeting endogenous bacterial RNA.

12 including long noncoding RNA, pre-mRNAs and bacterial RNAs.

13 tion termination events and 3' maturation of bacterial RNAs.

14 Rfam data, focusing on microRNAs, viral and bacterial RNAs.

15 l features in this RNA, which are typical of bacterial RNAs, activate PKR in TRAP-free and TRAP/l-Trp

16 onsistent with highly base-paired regions in bacterial RNA activating PKR.

17 Here we describe two reproducible methods of bacterial RNA amplification that will allow previously i

18 ways involved in innate immune activation by bacterial RNA and analyze the physiological relevance of

19 sis to enable simultaneous quantification of bacterial RNA and inflammatory proteins in a single syst

20 dying small molecules that can interact with bacterial RNA and interrupt cellular activities is a pro

21 une responses, the stimulatory properties of bacterial RNA and its role during infections have just b

22 We report that IFN-gamma suppressed bacterial RNA and LPS induced IL-1beta transcription in

23 iRNA) array analysis revealed an increase in bacterial RNA and multiple host miRNAs (miR-145, miR-146

24 h rifampin or chloramphenicol, inhibitors of bacterial RNA and protein synthesis, respectively, showe

25 IL-1beta and IL-18 production in response to bacterial RNA and the imidazoquinoline compounds R837 an

26 I cleaves double-stranded (ds) structures in bacterial RNAs and participates in diverse RNA maturatio

27 adation profiles of mRNA vaccines, viral and bacterial RNA, and other valuable species, new sensitive

28 gh cytosolic double-stranded RNA (dsRNA) and bacterial RNA are known to activate the NLRP3 inflammaso

29 RNase P RNAs of eukaryotes, in contrast to bacterial RNAs, are not catalytically active in vitro wi

30 flux and the primary use of amino acids and bacterial RNA as a tricarboxylic acid cycle carbon sourc

31 tion factor Rho associates with most nascent bacterial RNAs as they emerge from RNA polymerase.

32 Hfq is a bacterial RNA binding protein that facilitates small RNA

33 storage regulator A) is a widely distributed bacterial RNA binding protein that regulates translation

34 Hfq, a bacterial RNA-binding protein, was recently shown to con

35 Bacterial RNA-binding proteins can regulate transcriptio

36 The functions of many bacterial RNA-binding proteins remain obscure because of

37 ess adaptation remains at a nascent stage in bacterial RNA biology.

38 Bacterial RNA (bRNA) can induce cytokine production in m

39 hat contain all of the catalytic core of the bacterial RNA but lack phylogenetically variable, stabil

40 RNA contains a core structure similar to the bacterial RNA but lacks specific features that in bacter

41 Concurrent detection of bacterial RNA by NLRP3 and binding of LPS by pro-caspase

42 Detection of bacterial RNA by nucleic acid amplification tests (NAATs

43 The demonstration that nucleases guided by bacterial RNA can disrupt human genes represents a landm

44 sults propose a wide repertoire of potential bacterial RNA capping molecules, and provide mechanistic

45 ct of glucose caps set them apart from other bacterial RNA caps.

46 The widely occurring bacterial RNA chaperone Hfq is a key factor in the post-

47 similarities between NSP2 and the unrelated bacterial RNA chaperone Hfq suggest that accelerating RN

48 Hfq is a bacterial RNA chaperone involved in the posttranscriptio

49 Hfq, a bacterial RNA chaperone, stabilizes small regulatory RNA

50 f the proteins from different organisms, the bacterial RNA component, and a bacterial RNase P holoenz

51 rial RNA but lacks specific features that in bacterial RNAs contribute to catalysis and global stabil

52 Hfq also plays a key role in bacterial RNA decay by binding tightly to polyadenylate

53 results, together with recent insights into bacterial RNA decay, suggest a unifying model for the bi

54 Bacterial RNA degradation often begins with conversion o

55 Bacterial RNA degradation often begins with conversion o

56 Bacterial RNA degradosomes are multienzyme molecular mac

57 Recently, the subcellular organization of bacterial RNA degradosomes was found to present similari

58 n enzyme and are 50-fold less potent against bacterial RNA-dependent RNase P.

59 Nase that digests the high concentrations of bacterial RNA derived from symbiotic microflora.

60 Bacterial RNA-directed Cas9 endonuclease is a versatile

61 d little effect on invasion, indicating that bacterial RNA, DNA, and de novo protein synthesis are no

62 Our findings expand current knowledge of bacterial RNA editing in clinical contexts and provide a

63 A method was developed to detect 5' ends of bacterial RNAs expressed at low levels and to differenti

64 Bacterial RNA extracted directly from oropharyngeal swab

65 and blood was extracted at 8 hours to purify bacterial RNA for RNA-Seq with an Illumina platform.

66 The ability to identify and isolate bacterial RNA from animals or humans with infections has

67 In this study, we report that bacterial RNA from both Gram-positive and Gram-negative

68 a protocol for isolation of microarray-grade bacterial RNA from Escherichia coli K1 interacting with

69 tome, and examine the pitfalls in extracting bacterial RNA from the infected host compartment.

70 Bacterial RNA from the loops was retrieved at different

71 eloped a technique for specific isolation of bacterial RNA from within infected murine macrophages, a

72 In addition to functioning as a tether, the bacterial RNA gates access of substrates to the Ro60 cav

73 uctures and mechanisms of enzymes comprising bacterial RNA-guided CRISPR-Cas immune systems and deplo

74 dvent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and p

75 d genome-engineering approaches based on the bacterial RNA-guided nuclease Cas9.

76 CRISPR-Cas12a (Cpf1) is a bacterial RNA-guided nuclease that cuts double-stranded

77 Cas12a is a bacterial RNA-guided nuclease used widely for genome edi

78 These results suggest a role for the bacterial RNA helicase CrhR in RNase E-dependent mRNA pr

79 Bacterial RNA helicase rho is a genome sentinel that ter

80 modimerization domain with homology to other bacterial RNA helicases, and mass photometry data confir

81 unambiguously identify TLR8 as receptor for bacterial RNA in primary human monocyte-derived macropha

82 l-length protein in Escherichia coli package bacterial RNAs in amounts equivalent to the viral pregen

83 ically sequences all RNA, including host and bacterial RNA, in stool specimens.

84 racellular nucleic acid receptor involved in bacterial RNA-induced inflammasome activation and releas

85 -like receptor 8 (TLR8) recognizes viral and bacterial RNA, initiating inflammatory responses that ar

86 s following nocodazole arrest, and present a bacterial RNA-interactome for Escherichia coli.

87 Bacterial RNA is a strong inducer of type I IFN and NF-k

88 Bacterial RNA is an important trigger of inflammasome ac

89 ions are to be studied where the recovery of bacterial RNA is limited.

90 The amplification of bacterial RNA is required if complex host-pathogen inter

91 Bacterial RNA is the main driver of L lactis G121-mediat

92 RNA to generate the probes, especially when bacterial RNA is used for hybridization (50 microg of ba

93 the eucaryal RNase P RNA, in contrast to the bacterial RNA, is catalytically inactive in the absence

94 In fact, none of the bacterial RNA isolation methods, including the commercia

95 n 2 degrees BP is characterized by increased bacterial RNA mass and dominance of culture-confirmed pa

96 Further, we find that increased bacterial RNA mass correlates with reduced expression of

97 l role for cryopyrin in host defence through bacterial RNA-mediated activation of caspase-1, and prov

98 host factors including ribonuclease III for bacterial RNA-mediated adaptive immunity.

99 has been considered an important feature of bacterial RNA metabolism.

100 direct entry by RNase E has a major role in bacterial RNA metabolism.

101 se) plays synthetic and degradative roles in bacterial RNA metabolism; it is also suggested to partic

102 bacterial endotoxins and no contamination by bacterial RNA or DNA fragments.

103 The bacterial RNA polymeras holoenzyme consists of a catalyt

104 mechanistic function similarity between the bacterial RNA polymerase (RNAP) "switch region" and the

105 ntibiotic GE23077 (GE) binds directly to the bacterial RNA polymerase (RNAP) active-center 'i' and 'i

106 a nucleoside-analog inhibitor that inhibits bacterial RNA polymerase (RNAP) and exhibits antibacteri

107 The multi-subunit bacterial RNA polymerase (RNAP) and its associated regul

108 ocrosslinking to define interactions between bacterial RNA polymerase (RNAP) and promoter DNA in the

109 x was tracked by mapping cross-links between bacterial RNA polymerase (RNAP) and transcript RNA or te

110 Myxopyronin inhibits bacterial RNA polymerase (RNAP) by an unknown mechanism.

111 Rifamycin antibacterial agents inhibit bacterial RNA polymerase (RNAP) by binding to a site adj

112 proach was used to investigate inhibition of bacterial RNA polymerase (RNAP) by sorangicin (Sor), a m

113 ads to rapid and selective inhibition of the bacterial RNA polymerase (RNAP) by the 7 kDa T7 protein

114 anism, and structural basis of inhibition of bacterial RNA polymerase (RNAP) by the tetramic acid ant

115 e resonance energy transfer, we have defined bacterial RNA polymerase (RNAP) clamp conformation at ea

116 The sigma subunit of bacterial RNA polymerase (RNAP) confers on the enzyme th

117 Bacterial RNA polymerase (RNAP) containing the major var

118 Bacterial RNA polymerase (RNAP) coordinates transcriptio

119 e transcription from specific promoters, the bacterial RNA polymerase (RNAP) core enzyme must associa

120 to complete its infection in the absence of bacterial RNA polymerase (RNAP) enzyme activity.

121 The multisubunit bacterial RNA polymerase (RNAp) enzyme, which catalyses

122 nt of data on initiation of transcription by bacterial RNA polymerase (RNAP) has been obtained.

123 majority of biochemical characterizations of bacterial RNA polymerase (RNAP) have been focused; the p

124 The bacterial RNA polymerase (RNAP) holoenzyme consists of a

125 The bacterial RNA polymerase (RNAP) holoenzyme consists of a

126 The bacterial RNA polymerase (RNAP) holoenzyme containing si

127 Bacterial RNA polymerase (RNAP) holoenzyme initiates tra

128 The bacterial RNA polymerase (RNAP) is a multi-subunit, stru

129 Bacterial RNA polymerase (RNAP) is a multisubunit enzyme

130 Bacterial RNA polymerase (RNAP) is a validated target fo

131 The bacterial RNA polymerase (RNAP) is a validated target fo

132 uring transcription of protein-coding genes, bacterial RNA polymerase (RNAP) is closely followed by a

133 The sigma subunit of bacterial RNA polymerase (RNAP) is required for promoter

134 The sigma-subunit of bacterial RNA polymerase (RNAP) is required for promoter

135 Bacterial RNA polymerase (RNAP) is the central enzyme of

136 We report that bacterial RNA polymerase (RNAP) is the functional cellul

137 Transcript elongation by bacterial RNA polymerase (RNAP) is thought to be regulat

138 Bacterial RNA polymerase (RNAP) makes extensive contacts

139 Transcription termination by bacterial RNA polymerase (RNAP) occurs at sequences codi

140 The bacterial RNA polymerase (RNAP) recognizes promoters thr

141 The sigma subunit of bacterial RNA polymerase (RNAP) regulates gene expressio

142 Sequence-selective transcription by bacterial RNA polymerase (RNAP) requires sigma factor th

143 Bacterial RNA polymerase (RNAP) requires sigma factors t

144 Bacterial RNA polymerase (RNAP) responds to formation of

145 er specificity factor is distinct from other bacterial RNA polymerase (RNAP) sigma factors in that it

146 To explore the domain-scale flexibility of bacterial RNA polymerase (RNAP) throughout its functiona

147 well known that ppGpp and DksA interact with bacterial RNA polymerase (RNAP) to alter promoter activi

148 actors, the key regulatory components of the bacterial RNA polymerase (RNAP), direct promoter DNA bin

149 complex containing the major variant form of bacterial RNA polymerase (RNAP), Esigma(54), requires en

150 In bacterial RNA polymerase (RNAP), the bridge helix and sw

151 'switch region' - has been identified within bacterial RNA polymerase (RNAP), the enzyme that mediate

152 The bacterial RNA polymerase (RNAP), which catalyzes transcr

153 RapA is a bacterial RNA polymerase (RNAP)-associated Swi2/Snf2 ATP

154 pyrone antibiotic myxopyronin (Myx) inhibits bacterial RNA polymerase (RNAP).

155 factor GreA induces nucleolytic activity of bacterial RNA polymerase (RNAP).

156 the clinically important antibiotics, target bacterial RNA polymerase (RNAP).

157 bound to their natural enzymatic target, the bacterial RNA polymerase (RNAP).

158 rocin J25 (MccJ25) inhibits transcription by bacterial RNA polymerase (RNAP).

159 rocin J25 (MccJ25) inhibits transcription by bacterial RNA polymerase (RNAP).

160 therapy, stemming from its inhibition of the bacterial RNA polymerase (RNAP).

161 stant homologs of beta and beta' subunits of bacterial RNA polymerase (RNAP).

162 at ~60 nt s(-1) [comparable to the speed of bacterial RNA polymerase (RNAP)].

163 nds has been attributed to the inhibition of bacterial RNA polymerase activities, although the exact

164 domain that resembles the alphaCTD domain of bacterial RNA polymerase alpha; and this domain preferen

165 Bacterial RNA polymerase and a "sigma" transcription fac

166 Bacterial RNA polymerase and eukaryotic RNA polymerase I

167 e framework of a structure-function model of bacterial RNA polymerase and viral biology.

168 Intrinsic terminators of bacterial RNA polymerase are small (< approximately 30 b

169 Bacterial RNA polymerase arrested at the human site is r

170 act upon the sigma54-containing form of the bacterial RNA polymerase belong to the extensive AAA+ su

171 ents, conserved protein bS1 is excluded, and bacterial RNA polymerase binding site is blocked.

172 Bacterial RNA polymerase binds promoters in the form of

173 escribe a structural basis for inhibition of bacterial RNA polymerase by the antibiotic streptolydigi

174 gs highlight how nonconserved regions of the bacterial RNA polymerase can be targets of regulatory fa

175 nt termination of the S box leader region by bacterial RNA polymerase depends on SAM but not on methi

176 etermined the X-ray crystal structure of the bacterial RNA polymerase engaged in reiterative transcri

177 We found that in such complexes bacterial RNA polymerase exhibit an intrinsic endonucleo

178 rogen regulatory protein C (NtrC) contacts a bacterial RNA polymerase from distant enhancers by means

179 istance occur in an 81-bp core region of the bacterial RNA polymerase gene, rpoB.

180 o define the three-dimensional structures of bacterial RNA polymerase holoenzyme and the bacterial RN

181 dvance was the high-resolution structures of bacterial RNA polymerase holoenzyme and the holoenzyme i

182 ptional activators that act upon the sigma54 bacterial RNA polymerase holoenzyme belong to the extens

183 The bacterial RNA polymerase holoenzyme consists of a cataly

184 The structures of the bacterial RNA polymerase holoenzyme have provided detail

185 iously reported for the sigma subunit in the bacterial RNA polymerase holoenzyme, consisting of a ser

186 the successive steps of promoter opening by bacterial RNA polymerase holoenzyme.

187 Bacterial RNA polymerase holoenzymes containing the sigm

188 nts on diverse DNA probes were used with two bacterial RNA polymerase holoenzymes that differ in how

189 p. ID38640, a soil isolate that produces the bacterial RNA polymerase inhibitor pseudouridimycin.

190 as become clear that promoter recognition by bacterial RNA polymerase involves interactions not only

191 Bacterial RNA polymerase is a common target for many ant

192 Bacterial RNA polymerase is a potent target for antibiot

193 health as pathogens and commensals, and the bacterial RNA polymerase is a proven target for antibiot

194 Bacterial RNA polymerase is able to initiate transcripti

195 The dissociable sigma subunit of bacterial RNA polymerase is required for the promoter-sp

196 The sigma subunit of bacterial RNA polymerase is strictly required for promot

197 his study finds that individual molecules of bacterial RNA polymerase move in single base-pair steps

198 The sigma subunits of bacterial RNA polymerase occur in many variant forms and

199 ed the positions of the binding sites within bacterial RNA polymerase of the small-molecule inhibitor

200 The sigma-to-core protein interaction in bacterial RNA polymerase offers a potentially specific t

201 standing of the mechanistic underpinnings of bacterial RNA polymerase regulation.

202 ubtilis, a member of the sigma(70)-family of bacterial RNA polymerase sigma factors, is negatively re

203 The bacterial RNA polymerase sigma subunits are key particip

204 etween termination mechanisms of Pol III and bacterial RNA polymerase suggests that hairpin-dependent

205 l evidence from cryo-EM demonstrating that a bacterial RNA polymerase that is paused proximally to th

206 entified a few "hot spots" on the surface of bacterial RNA polymerase that mediate its interactions w

207 (70) as a protein factor that was needed for bacterial RNA polymerase to accurately transcribe a prom

208 (sigma(32) in Escherichia coli) directs the bacterial RNA polymerase to promoters of a specific sequ

209 Sigma 54 is a required factor for bacterial RNA polymerase to respond to enhancers and dir

210 reconstruction to 3 angstrom resolution of a bacterial RNA polymerase with preferred orientation, con

211 Rifampicin, which inhibits bacterial RNA polymerase, provides one of the most effec

212 by which the antibiotic myxopyronin inhibits bacterial RNA polymerase, suggesting a new target region

213 The clamp closure in bacterial RNA polymerase, the ratcheting of 30S and 50S

214 In bacterial RNA polymerase, this motif, the zinc binding d

215 bacterial RNA polymerase holoenzyme and the bacterial RNA polymerase-promoter open complex in soluti

216 s in the structurally unrelated multisubunit bacterial RNA polymerase.

217 It inhibits transcription by bacterial RNA polymerase.

218 phage-encoded activator protein Mor and the bacterial RNA polymerase.

219 uced by Streptomyces lydicus, which inhibits bacterial RNA polymerase.

220 protoknot antibacterial peptide that targets bacterial RNA polymerase.

221 Peptide microcin J25 (MccJ25) inhibits bacterial RNA polymerase.

222 l domains of the alpha and sigma subunits of bacterial RNA polymerase.

223 the phage-encoded activator protein Mor and bacterial RNA polymerase.

224 cent determination of the X-ray structure of bacterial RNA polymerase.

225 RNA polymerase II and subunits RpoB-RpoC of bacterial RNA polymerase.

226 This technique was used to study the bacterial RNA polymerase/lacUV5 DNA open promoter comple

227 Most bacterial RNA polymerases (RNAP) contain five conserved

228 Bacterial RNA polymerases (RNAPs) are targets for antibi

229 trinsic termination signals for multisubunit bacterial RNA polymerases (RNAPs) encode a GC-rich stem-

230 Transcription initiation complexes formed by bacterial RNA polymerases (RNAPs) exhibit dramatic speci

231 Recognition of promoters in bacterial RNA polymerases (RNAPs) is controlled by sigma

232 posed of plastid-encoded subunits similar to bacterial RNA polymerases (RNAPs) stably bound to a set

233 eptolydigin class of antibiotics that target bacterial RNA polymerases (RNAPs).

234 treptolydigin (Stl) is a potent inhibitor of bacterial RNA polymerases (RNAPs).

235 pe can be rate-limiting for transcription by bacterial RNA polymerases and RNA polymerase II of highe

236 Sigma subunits of bacterial RNA polymerases are closely involved in many s

237 direct DNA interaction (as sigma subunits of bacterial RNA polymerases do) or indirectly by their act

238 Here we have transcribed with phage and bacterial RNA polymerases, a human DNA sequence previous

239 scription, because unlike the eucaryotic and bacterial RNA polymerases, it is a single subunit enzyme

240 criptional initiation by pol II, pol III and bacterial RNA polymerases: a preformed single-stranded D

241 Screening for bacterial RNAs produced in response to host interactions

242 A and analyze the physiological relevance of bacterial RNA recognition during infections.

243 The significance of bacterial RNA recognition for initiating innate immune r

244 iew the mechanisms and functions of selected bacterial RNA regulators and discuss their importance in

245 argetRNA, that predicts the targets of these bacterial RNA regulators.

246 e, but whether this is a general property of bacterial RNA remains unclear as are the pathways involv

247 Here we report a new bacterial RNA repair complex that performs RNA repair li

248 ase (CthPnk), the 5'-end-healing module of a bacterial RNA repair system, catalyzes reversible phosph

249 ase (CthPnk), the 5' end-healing module of a bacterial RNA repair system, catalyzes reversible phosph

250 ifferent between the eukaryotic RNAi and the bacterial RNA repair.

251 ocess of analyzing RNA-seq data sets, making bacterial RNA-seq analysis a routine process that can be

252 SPARTA is a reference-based bacterial RNA-seq analysis workflow application for sing

253 es based on VLMC were applied to compare the bacterial RNA-Seq and metatranscriptomic datasets.

254 To make bacterial RNA-seq data analysis more accessible, we deve

255 d Rockhopper that supports various stages of bacterial RNA-seq data analysis, including aligning sequ

256 ructures and transcriptomes, for analysis of bacterial RNA-seq data and de novo transcriptome assembl

257 used for efficient and accurate analysis of bacterial RNA-seq data, and that it can aid with elucida

258 nd offers accurate and efficient analysis of bacterial RNA-seq data.

259 e demonstrate that IgnaviCas9 can be used in bacterial RNA-seq library preparation to remove unwanted

260 Bornet et al. apply a low-input bacterial RNA-seq pipeline to transcriptionally profile

261 Cost-effective bacterial RNA-seq requires efficient physical removal of

262 SPARTA provides an easy-to-use bacterial RNA-seq transcriptional profiling workflow to

263 Simple Program for Automated reference-based bacterial RNA-seq Transcriptome Analysis (SPARTA).

264 Bacterial RNA sequencing (RNA-seq) is a powerful approac

265 Many tools exist in the analysis of bacterial RNA sequencing (RNA-seq) transcriptional profi

266 However, the role of single bacterial RNA species in immune activation has not been

267 Small, non-coding bacterial RNAs (sRNAs) have been shown to regulate a ple

268 Small non-coding bacterial RNAs (sRNAs) play important regulatory roles i

269 A major class of small bacterial RNAs (sRNAs) regulate translation and mRNA sta

270 In summary, we present a dynamic bacterial RNA structurome and find that the expression o

271 also inhibited transcription/translation of bacterial RNA, suggesting a mechanism for its antibiotic

272 the binding site for compounds that inhibit bacterial RNA synthesis and kill bacteria.

273 polymerase (RNAP), the enzyme that mediates bacterial RNA synthesis.

274 tructural complex from a bacteriophage and a bacterial RNA-synthesizing machine.

275 However, the features of bacterial RNA that activate PKR are unknown.

276 ligo-dT primers after polyadenylation of the bacterial RNA, the second using a set of mycobacterial a

277 analyses, we report the discovery of several bacterial RNA thermometers in the 5' untranslated region

278 Additionally, we used the ratio of human to bacterial RNA to adjust the input RNA to include equal a

279 Moreover, the contribution of bacterial RNA to the induction of innate immune response

280 able to distinguish between amplification of bacterial RNA transcripts and the DNA templates that enc

281 iofilms, and the eRNA is enriched in certain bacterial RNA transcripts.

282 However, as bacterial RNA typically lacks a poly(A) tail, standard s

283 nstrates that PKR can signal the presence of bacterial RNAs under physiological ionic conditions and

284 dimensional structures of three large ornate bacterial RNAs using cryo-electron microscopy (cryo-EM).

285 quencing expanded the known diversity of the bacterial RNA virome, suggesting that additional ribovir

286 eukaryotes and even more distant from known bacterial RNA viruses.

287 Moreover, TLR8-dependent detection of bacterial RNA was critical for triggering monocyte activ

288 l as the priming for caspase-1 activation by bacterial RNA was dependent on UNC93B, an endoplasmic re

289 In addition, bacterial RNA was stained in liver sections using 16sRNA

290 osslinking results and crystal structures of bacterial RNAs, we develop a tertiary structure model of

291 ation and IL-1beta production by transfected bacterial RNA were absent in MyD88-deficient cells but i

292 udy, we show that human monocytes respond to bacterial RNA with secretion of IL-6, TNF, and IFN-beta,

293 Bacterial RNA within streptococci was also a dominant st

294 with bacteria engulfed are a major source of bacterial RNA within the tumor microenvironment (TME) an

295 One physiological change a bacterial RNA would face in a human cell is a decrease i